MA-1H5

antibody from Molecular Innovations
Targeting: VLDLR CARMQ1, CHRMQ1, VLDLRCH
Provider product page for MA-1H5
ELISA
Blocking/Neutralizing

Antibody data

Product number
MA-1H5 - Provider product page
Provider
Molecular Innovations
Product name
Anti-VLDLR
Antibody type
Monoclonal
Antigen
Recombinant protein fragment
Description
Inhibitory Anti Human VLDL receptor, clone 1H5. Monoclonal antibody produced in mouse. Useful for ELISA. Binds to an epitope on the C-terminus of VLDL receptor ligand binding domain (amino acids 191-355, UniProtKB: locus VLDLR_HUMAN, accession P98155) and blocks apoE4 binding. Purified by immobilized Protein A. IgG1 class. References: Functional domains of the very low density lipoprotein receptor: molecular analysis of ligand binding and acid-dependent ligand dissociation mechanisms. Mikhailenko I et al. Journal of Cell Science 112, 3269-3281 (1999). The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. Ruiz J et al. Journal of Lipid Research 46, 1721-1731 (2005).
Reactivity
Human
Host
Mouse
Epitope
C-terminus of VLDL receptor ligand binding domain (191-355)
Isotype
IgG
Antibody clone number
1H5
Vial size
500 µl
Concentration
2 mg/ml
Storage
-70 C
VLDLR protein structure - MA-1H5 shown in red.